Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH Highlights Advanced Imaging, Neurostim Technologies In Funding Appeal

This article was originally published in The Gray Sheet

Executive Summary

Further development of medical technologies to advance brain disease diagnoses, treat spinal cord injuries and manage pain without the use of addictive opioids would be key beneficiaries if additional funding from Congress for the National Institutes of Health comes through, NIH head Francis Collins told appropriators.

You may also be interested in...



Gottlieb Touts Devices For Pain Control To Help Solve Opioid Crisis

Devices, or drug-delivery device, alternatives for pain control may provide at least a partial solution to the nation's opioid abuse epidemic, FDA Commissioner-nominee Scott Gottlieb said at his April 5 confirmation hearing before the Senate Health, Education, Labor, and Pensions Committee.

White House Grants $86M To Propel BRAIN, Precision Medicine Initiatives

The Obama administration announced a total of $86m in new grant funds to propel the National Institute of Health’s BRAIN Initiative and Precision Medicine Initiative forward, among other innovative science research programs.

House Panel Passes Infectious-Disease Fighting Fund

The House Appropriations Committee's Labor/HHS Subcommittee approved an additional $300m in funding next year for an "Infectious Disease Rapid Response Reserve Fund" to be run by the Centers for Disease Control and Prevention.

Related Content

Topics

UsernamePublicRestriction

Register

MT034629

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel